• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Rheumatoid Arthritis

Marketing

EMA cracks down on JAK drugs with new limitations

The EMA restrictions follow FDA's policy rolled out last year limiting JAK inhibitors' use behind a TNF blocker in inflammatory diseases.
Angus Liu Oct 28, 2022 10:20am

ANI focuses on data insights to ramp up Cortrophin

Jun 24, 2022 8:10am

NIH study finds arthritis meds reduce COVID death risk

Jun 2, 2022 4:33pm

Trial win sets up AbbVie's Rinvoq up for likely Crohn's approval

May 12, 2022 9:52am

Lilly's Olumiant gets full FDA nod for COVID patients on oxygen

May 11, 2022 8:50am
image-icon

The top advertisers in Big Pharma

Apr 25, 2022 3:00am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy